Carlsbad, CA, United States of America

Alain Phillippe Vasserot

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Atyr Pharma, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Phillippe Vasserot. Retrieved from https://idiyas.com/inventor/alain-phillippe-vasserot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alain Phillippe Vasserot

Introduction

Alain Phillippe Vasserot is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of thrombopoiesis. His work has the potential to impact treatments for conditions such as thrombocytopenia.

Latest Patents

Vasserot holds a patent titled "Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides." This patent describes thrombopoietic compositions that comprise tyrosyl tRNA synthetase polypeptides, including truncations and variants. The methods outlined in the patent focus on using these compositions to treat conditions that benefit from increased thrombopoiesis.

Career Highlights

Alain Phillippe Vasserot is associated with Atyr Pharma, Inc., where he continues to advance his research and innovations. His work at Atyr Pharma emphasizes the development of therapies that leverage his patented compositions.

Collaborations

Vasserot collaborates with esteemed colleagues, including Rajesh Belani and Jeffry Dean Watkins. Their combined expertise contributes to the innovative environment at Atyr Pharma.

Conclusion

Alain Phillippe Vasserot's contributions to biotechnology, particularly through his patent on thrombopoietic compositions, highlight his role as an influential inventor in the field. His ongoing work at Atyr Pharma promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…